http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0163697-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c07629781dc2af57fa6d3250f3d905e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 1984-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f729ec62070e94ff01a38f16dfff78 |
| publicationDate | 1985-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0163697-A1 |
| titleOfInvention | QUICK METHOD FOR INTERRUPTING NARCOTIC ADDICTION SYNDROME. |
| abstract | It has been observed that administration to a heroin addict of ibogaine, HCl of ibogaine or other non-toxic salts of ibogaine, an alkaloid of the apocynaceae family, unexpectedly interrupts the physiological and psychological effects of the syndrome. opiate addiction. The effectiveness of a single treatment lasted approximately 6 months, and the effectiveness of a series of 4 treatments lasted approximately 3 years. The treatments consisted in orally administering doses of ibogaine or its salts at concentrations between 6 mg / kg and 19 mg / kg. The minimum effective dose was 400 mg and it was noted that doses in excess of 1000 mg were not required. The treatments were effective in 71% of the cases. |
| priorityDate | 1983-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.